I don't know anyone who would consider $4.00/share a loss.
At this time a buyout would be closer to $0.40/share and it would be a top 5 buyout premium of all time in biotech.
Just to highlight how ludicrous $4.00/share is.
The highest biotech buyout premium ever was Allergan buying Tobira for a 1500% premium (16x the share price).
In IPIX terms: 16 x $0.05 = $0.80/share.
$4/share would be 5x that previous record.
After all we have been through, without further successful trials, do you really believe you're holding the lightning in the bottle that is five times better than the all-time record buyout premium?
Really?
Don't you think we would have struck a deal on Kevetrin or B-ABSSSI or B-OM or B-UC if we could have? Instead we increased the share count 250% the past five years to have essentially the same money and pipeline we did then.
Leo would not have diluted us like that if he had a superior option in monetizing the pipeline. Given the abysmal B-UP deal terms I'm not surprised he chose the dilution route if that is representative of what he can negotiate.
$4.00/share....we should all be praying to whatever gods we believe in that we get $0.40/share.
I would be more than happy with that. So hard to speculate on this. Hope Leo realizes what he may have and doesn't settle for pennies either just because it is currently beaten down. However, gov't funding or partnership would also be nice to see. Go IPIX!